Remote within the New York/New Jersey territory, with up to 30% travel outside the territory and overnight trips as needed.
Alcon provides eye care products and vision solutions to improve how people see. It develops and manufactures devices and consumables for eye health, including cataract surgery equipment and intraocular lenses, retinal health therapies, and contact lenses, distributed through eye care professionals, hospitals, and consumers. The products work by supporting eye surgery, protecting and restoring vision, or correcting vision with lens-based options, backed by research and development and a global distribution network. Alcon differentiates itself with a broad, end-to-end portfolio across the eye care continuum, a strong emphasis on research and development, strategic partnerships with healthcare providers, and a commitment to diversity and inclusion. Its goal is to enhance vision and quality of life by delivering reliable, high-quality eye care solutions and advancing the science of eye health.
Company Size
10,001+
Company Stage
IPO
Headquarters
Geneva, Switzerland
Founded
1945
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Medical, dental, & vision coverage
HSA Medical Plan
PTO
Paid Parental leave
401k
Retirement Plan Company Contribution
Low payroll deductions
Tuition Reimbursement Program
Annual Bonus
Free Family Contact Lens Program
12 Company Paid Holidays
Alcon has launched Systane PRO Preservative-Free in Canada, its longest-lasting dry eye relief formula. The triple-action eye drops provide up to 12 hours of symptom relief for all types of dry eyes. The formula contains hyaluronic acid, HP-guar, nano-sized lipids, and propylene glycol to hydrate, restore, and protect dry eyes. It works by covering the eye surface for instant hydration, providing long-lasting lubrication, and stabilising the tear film to prevent evaporation. Dry eye disease affects an estimated 6 million Canadians and 1.6 billion people globally. Systane is the number one global brand of artificial tears. The new preservative-free formulation addresses symptoms caused by ageing, environmental factors, and digital device use.
Alcon launches UNITY M, a premium ophthalmic microscope delivering precise control. Alcon announced the initial commercial launch of UNITY M, an Alcon brand premium surgical microscope that delivers precise control to ophthalmic surgeons, in select markets including the U.S. and Japan followed by Europe.[1,2,4] UNITY M will be featured at the upcoming Congress of the European Society of Cataract and Refractive Surgeons (ESCRS). The microscope is the latest addition to Alcon's UNITY platform, combining advanced optics, novel illumination, improved ergonomics, and intuitive usability in a modular design that enables practice-specific customization and future scalability.[1-3,5-7, ,‡,§] "The idea behind the UNITY platform is to develop clinic-based and operating room equipment solutions with a seamless user experience that improve surgical workflows," said Ian Bell, SVP and Chief Operating Officer of Alcon. "By partnering closely with Eye Care Professionals to understand their most significant unmet needs, we developed UNITY M to provide a flexible, future-ready visualization platform that gives surgeons precise control and personalization in the operating room."
Alcon adds second Global Capability Center in Bangalore. * September 7, 2026 Alcon, one of the world's largest eye-care medical device companies, has expanded its Global Capability Center operations in India with the opening of a second Alcon Global Services facility in Bengaluru. The expansion is notable not simply because Alcon is adding office capacity in India, but because of the range of global activities being performed there. The Bangalore operations support functions including information technology, research and development, quality, customer operations, supply chain analytics, finance and digital transformation. Alcon's decision to establish a second location in the same metropolitan area also illustrates the scale that the city has achieved as a center for multinational healthcare and technology operations. The two Alcon locations are roughly an hour apart by car under typical Bengaluru traffic conditions. In a metropolitan area of Bangalore's size, separate locations can potentially provide access to different pools of employees and make commuting more practical for workers living in different parts of the city. Alcon has not, however, identified that as the reason for selecting the second location. This is my assessment having lived in Bangalore and having traveled to this city many times in recent years Gopal Sharma, who leads Alcon Global Services, described the expansion as an investment in talent and future capabilities rather than simply an addition of office space. The company expects the new facility to increase its ability to recruit skilled professionals and support operations elsewhere in the Alcon organization. The type of work being performed is also significant. Global Capability Centers in India were once associated primarily with lower-cost back-office functions such as transaction processing, finance and IT support. That model has changed substantially. Multinational companies increasingly use their India centers for engineering, product development, data analytics, cybersecurity, artificial intelligence and other activities closely connected to their core businesses. While Alcon is not our client, we firmly believe that medical device companies can benefit greatly from leveraging technical talent in many of India's cities. Alcon's operation reflects that evolution. Research and development, quality, supply chain analytics and digital transformation place at least part of the India organization closer to the company's technology and operational decision-making than a conventional shared-services center would be. For medical device companies, India offers a particularly relevant combination of software, engineering and healthcare talent. Modern medical devices increasingly combine physical products with software, data, digital platforms and connected technologies, making some of the skills available in India's technology centers directly applicable to global medical device development. Bangalore, Hyderabad, Delhi NCR (Noida and Gurgaon) and Pune have become one of the principal beneficiaries of this shift. Established technology industry, large engineering workforce and growing life sciences ecosystem have attracted GCC investments from multinational healthcare, pharmaceutical and medical technology companies. Alcon also views India as an important emerging market for its products, giving the country a dual role within the company: it is both a commercial healthcare market and a location from which employees support Alcon's global organization. Opening a second facility in the same city suggests that Alcon sees sufficient value in the city's talent base to continue concentrating operations there rather than shifting the additional capacity to another Indian city. However other companies have chosen to expand their talent people and gain redundancy against disaster by diversifying across multiple locations in India. There is no single right answer. More broadly, the expansion provides another example of how the role of India within multinational medical device companies is changing. The attraction is no longer limited to lower operating costs. For companies such as Alcon, India is increasingly a source of engineering and specialized talent that can participate in R&D, analytics, digital transformation and other work supporting the global business. About amritt. Who we are. Amritt Inc. is a management advisory service facilitating trade between the world and India. Amritt was founded in 2003 and since then it has provided guidance to western companies in entering new markets, global strategy execution, finding and managing supplier partners, and establishing overseas offices. Our primary focus is in helping American, Canadian and European executives to attain success in India.
Alcon launches Unity M ophthalmic microscope. September 04, 2026 Add topic to email alerts Key takeaways: * The microscope is designed for both anterior and posterior segment surgical procedures. * In addition to visualization features, Unity M allows for modular updates over time. Alcon launched Unity M, a surgical microscope designed to increase surgical precision with advanced visualization features for both anterior and posterior segment surgeons, according to a press release. "Through our collaboration with eye care professionals, we heard a consistent need for greater control and reliable visualization during surgery," Sergio Duplan, senior vice president, president, Americas, at Alcon, told Healio. "That's why we built Unity M specifically for ophthalmology, delivering a stable red reflex, color tunable illumination and optimized depth of field to help surgeons visualize tissue more clearly and operate with confidence." The base model's red reflex zone is designed to help maintain consistent visualization across pupil sizes and microscope positions, the release said, while color tunable illumination technology provides improved contrast and tissue detail. Commercial rollout will begin in the U.S. and Japan this year, followed by additional markets. The device is the third addition to Alcon's Unity platform and is built to integrate seamlessly into Alcon's wider portfolio as well as to allow surgeons to adopt customized, modular updates over time, tailoring the system to their clinical needs. Unity M has received CE mark and regulatory approvals in the U.S., India, Europe, Canada and Japan, according to the release, and will be featured at the European Society of Cataract and Refractive Surgeons meeting this month. Published by: Sources/Disclosures. Disclosures: Duplan reports being senior vice president, president, Americas, at Alcon. Ask a clinical question and tap into Healio AI's knowledge base. * PubMed, enrolling/recruiting trials, guidelines * Clinical Guidance, Healio CME, FDA news * Healio's exclusive daily news coverage of clinical data
Alcon launches new surgical microscope. Alcon has launched a new surgical microscope for eye surgery. 03.09.2026 06:15 The device, named "Unity M," is intended to give surgeons a more stable view during operations, including through an improved red reflex zone and adjustable color lighting, as the ophthalmology specialist Alcon announced on Thursday. The microscope is modular and can be expanded according to the needs of the practice, the statement continued. "Unity M" is approved in the USA, Japan, Canada, India, and Europe. Delivery began in September, and market introduction will initially be carried out in countries such as the USA and Japan, and later in Europe. The device will also be presented at the upcoming congress of the European Society of Cataract and Refractive Surgery, it was said.